Trevi Therapeutics, Inc. (TRVI) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

Margin (%)

Operating Expenses

Research And Development ExpensesSelling General And Administrative Expenses
02M5M8M10M12M15M18M20MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EBITDA

EBITDA
-20M-17M-15M-12M-10M-7M-5M-2M1Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

EPS

Revenue Variation (%)

Income Variation (%)

Gross Profit VariationOperating Income Variation
048111519222630Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Revenue YoY Variation (%)

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY Variation
0815223038455260Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Price-to-Earning Ratio

P/E Ratio
-40-35-30-25-20-14-9-41Q4 2024Q1 2025Q2 2025Q3 2025

Income Breakdown

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0625K1M2M2M3M4M4M5MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Per Share Metrics

Expense Ratios

💰 Cash Flow Statement

Operating Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
04M8M11M15M19M22M26M30MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Free Cash Flow

Cash At End Of Period
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025

Cash Flow to Debt Ratio

Net Cash Provided By Operating ActivitiesNet Cash Used Provided By Financing Activities
025M50M75M100M125M150M175M200MQ4 2024Q1 2025Q2 2025Q3 2025Q4 2025
🏦 Balance Sheet
📈 Key Metrics